Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.9B | 4.9B | 5.0B | 5.1B |
Cost of revenue | 1.9B | 2.0B | 2.0B | 2.0B |
Gross profit | 3.0B | 3.0B | 3.1B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.9B | 1.9B | 2.0B | 1.9B |
Other operating expenses | 13M | — | 30M | 35M |
Operating income | 1.1B | 1.1B | 1.1B | 1.1B |
Non operating interest income | ||||
Income | 15M | — | — | — |
Expense | 66M | — | — | — |
Other income expense | -72M | -82M | -23M | -22M |
Pretax income | 953M | 993M | 986M | 1.0B |
Tax provision | 227M | 214M | 210M | 243M |
Net income | 726M | 779M | 776M | 767M |
Basic EPS | 0.9 | 0.9 | 0.9 | 0.9 |
Diluted EPS | 0.9 | 0.9 | 0.9 | 0.9 |
Basic average shares | 812M | 816M | 817.7M | 819.7M |
Diluted average shares | 815M | 819.7M | 822.5M | 823.7M |
EBITDA | 1.2B | 1.2B | 1.2B | 1.2B |
Net income from continuing op. | 726M | 779M | 775M | 766M |
Minority interests | -36M | -40M | -39M | -36M |
Preferred stock dividends | — | — | — | — |